Clinical Trials Logo
  1. Home
  2. Valve Heart Disease
  3. NCT03885180
  4. Details
NCT03885180 Clinical Trial

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Valve Heart Disease Clinical Trial

— REDUCE  

Official title:
Randomized Evaluation of D-dimer Guiding Duration of Oral Anticoagulation Therapy in Patients With Bioprosthetic Heart Valves

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03885180
Other study ID # 2019-P-026
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 20, 2019
Est. completion date March 30, 2021

Study information
Verified date March 2019
Source Wuhan Asia Heart Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Guidelines recommended that patients with bioprosthetic heart valves (BHV) only need 6 months oral anticoagulation therapy after operation. However, a small part of patients still suffered thrombotic events after withdrawal of warfarin, which means these patients may need extend anticoagulation therapy. D-dimer, a sensitive marker of thrombosis or prethromboembolism state. Previous studies have demostrated that patients with elevated D-dimer levels have significant more clinical outcomes than those with nagative D-dimer levels. The aim of this study was to evaluate whether D-dimer could guide the duration of oral anticoagulation therapy in patients with BHV.

Description:

Patients with BHV were screened and enrolled in this study. D-dimer levels were measured in the sixth months after BHV operation but before withdrawal of warfarin. Patients with elevated D-dimer were randomized to extend anticoagulation therapy group and routine stopping anticoagulation group.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date March 30, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients received BHV within 3 months

Exclusion Criteria:

- Recently throboemblism within 6 months

- Recently bleedings within 3 months

- Evaluated lifetime less than 2 years

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Warfarin Sodium
Extending warfarin anticoagulation

Locations
Country Name City State
China Wuhan Asia Heart Hospital Wuhan Hubei

Sponsors (1)
Lead Sponsor Collaborator
Wuhan Asia Heart Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Thrombotic events Stroke, DVT, PE, valve thrombosis 24 months
Primary Bleeding events 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT06066970 - Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Recruiting NCT05079672 - Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery Phase 4
Completed NCT03347851 - Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
Active, not recruiting NCT03539458 - Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification N/A
Completed NCT04328090 - Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship N/A
Recruiting NCT04359030 - Freestyle-Perimount Calcification Comparison
Completed NCT04958668 - Prospective Evaluation of Volatile Sedation After Heart Valve Surgery N/A
Completed NCT04598360 - Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine) N/A
Not yet recruiting NCT04118621 - Role of Chest Ultrasound in Detection of Post-operative Pulmonary Complications After Cardiothoracic Surgery
Recruiting NCT06387446 - Allogeneic Valve Transplantation N/A
Recruiting NCT04843072 - Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis N/A
Completed NCT05804500 - RecoveryPlus Telerehab Platform Pilot Study N/A
Completed NCT06154018 - Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass. N/A
Recruiting NCT06041308 - Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve Versus Mechanical Valve
Suspended NCT01571791 - Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery Phase 2
Completed NCT06261788 - Efficacy and Safety of the Sync-AV II Temporary Cardiac Pacing Catheter N/A
Completed NCT06079008 - The Association of Cardiac Valve Calcification and 1-year Mortality After Lower-extremity Amputation in Diabetic Patients
Completed NCT04372654 - Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients N/A
Active, not recruiting NCT03661398 - Caisson Transcatheter Mitral Valve Replacement (TMVR) N/A
Recruiting NCT03595423 - SPAnish Aortic VALVE Multicentric Study